Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Enfermedad de Parkinson y Parkinsonismo Parkinson’s disease & Parkinsonism 3465 artículos Viendo del 1 al 40 de 3465 artículos
Pub MED

Healthcare Data Analytics for Parkinson's Disease Patients: A Study of Hospital Cost and Utilization in the United States.NUEVO

Mukherjee S, Wu H, Jones J.
AMIA Annu Symp Proc. 2017 Feb 10;2016:1950-1958. eCollection 2016.
Pub MED

Analysis of pramipexole dose-response relationships in Parkinson's disease.

Wang Y, Sun SG, Zhu SQ, Liu CF, Liu YM, Di Q, Shang HF, Ren Y, Xiang W, Chen SD.
Drug Des Devel Ther. 2016 Dec 23;11:83-89. doi: 10.2147/DDDT.S112723.
Pub MED

Changes in functional organization and white matter integrity in the connectome in Parkinson's disease.

Tinaz S, Lauro PM, Ghosh P, Lungu C, Horovitz SG.
Neuroimage Clin. 2016 Dec 19;13:395-404. doi: 10.1016/j.nicl.2016.12.019.
Pub MED

Psychometric properties of a Norwegian adaption of the Barratt Impulsiveness Scale-11 in a sample of Parkinson patients, headache patients, and controls.

Lindstrøm JC, Wyller NG, Halvorsen MM, Hartberg S, Lundqvist C.
Brain Behav. 2016 Nov 23;7(1):e00605. doi: 10.1002/brb3.605.
Pub MED

Serum uric acid levels in Parkinson's disease and related disorders.

Sakuta H, Suzuki K, Miyamoto T, Miyamoto M, Numao A, Fujita H, Watanabe Y, Hirata K.
Brain Behav. 2016 Oct 31;7(1):e00598. doi: 10.1002/brb3.598.
Pub MED

Side-of-onset of Parkinson's disease in relation to neuropsychological measures.

Modestino EJ, Amenechi C, Reinhofer A, O'Toole P.
Brain Behav. 2016 Oct 19;7(1):e00590. doi: 10.1002/brb3.590.
Pub MED

Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease.

Foo H, Mak E, Chander RJ, Ng A, Au WL, Sitoh YY, Tan LC, Kandiah N.
Neuroimage Clin. 2016 Dec 12;14:37-42. doi: 10.1016/j.nicl.2016.12.008.
Pub MED

Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometry.

Nürnberger L, Gracien RM, Hok P, Hof SM, Rüb U, Steinmetz H, Hilker R, Klein JC, Deichmann R, Baudrexel S.
Neuroimage Clin. 2016 Dec 21;13:405-414. doi: 10.1016/j.nicl.2016.12.025.
Pub MED

[Evidence-based treatment of psychosis associated with Parkinson's disease].

Haussmann R, Bauer M, Donix M.
Nervenarzt. 2016 May;87(5):543-51. doi: 10.1007/s00115-015-4438-y. German.
Pub MED

Creative Thinking, Professional Artists, and Parkinson's Disease.

Canesi M, Rusconi ML, Moroni F, Ranghetti A, Cereda E, Pezzoli G.
J Parkinsons Dis. 2016;6(1):239-46. doi: 10.3233/JPD-150681.
Pub MED

Impact of Falls on Physical Activity in People with Parkinson's Disease.

Hiorth YH, Larsen JP, Lode K, Tysnes OB, Godfrey A, Lord S, Rochester L, Pedersen KF.
J Parkinsons Dis. 2016;6(1):175-82. doi: 10.3233/JPD-150640.
Pub MED

Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease.

Mao ZL, Modi NB.
J Clin Pharmacol. 2016 Aug;56(8):974-82. doi: 10.1002/jcph.683.
Pub MED

Variability of Anticipatory Postural Adjustments During Gait Initiation in Individuals With Parkinson Disease.

Lin CC, Creath RA, Rogers MW.
J Neurol Phys Ther. 2016 Jan;40(1):40-6. doi: 10.1097/NPT.0000000000000112.
Pub MED

Review: Parkinson's disease: from synaptic loss to connectome dysfunction.

Bellucci A, Mercuri NB, Venneri A, Faustini G, Longhena F, Pizzi M, Missale C, Spano P.
Neuropathol Appl Neurobiol. 2016 Feb;42(1):77-94. doi: 10.1111/nan.12297. Review.
Pub MED

AAV2-Neurturin for Parkinson's Disease: What Lessons Have We Learned?

Kordower JH.
Methods Mol Biol. 2016;1382:485-90. doi: 10.1007/978-1-4939-3271-9_32.
Pub MED

Viral Vector-Based Modeling of Neurodegenerative Disorders: Parkinson's Disease.

Fischer DL, Gombash SE, Kemp CJ, Manfredsson FP, Polinski NK, Duffy MF, Sortwell CE.
Methods Mol Biol. 2016;1382:367-82. doi: 10.1007/978-1-4939-3271-9_26.
Pub MED

Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons.

Grünewald A, Rygiel KA, Hepplewhite PD, Morris CM, Picard M, Turnbull DM.
Ann Neurol. 2016 Mar;79(3):366-78. doi: 10.1002/ana.24571.
Pub MED

Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines.

Alam Q, Alam MZ, Mushtaq G, Damanhouri GA, Rasool M, Kamal MA, Haque A.
Curr Pharm Des. 2016;22(5):541-8. Review.
Pub MED

Whole-Exome Sequencing in Familial Parkinson Disease.

Farlow JL, Robak LA, Hetrick K, Bowling K, Boerwinkle E, Coban-Akdemir ZH, Gambin T, Gibbs RA, Gu S, Jain P, Jankovic J, Jhangiani S, Kaw K, Lai D, Lin H, Ling H, Liu Y, Lupski JR, Muzny D, Porter P, Pugh E, White J, et al.
JAMA Neurol. 2016 Jan;73(1):68-75. doi: 10.1001/jamaneurol.2015.3266.
Pub MED

A Case of Rapid Eye Movement Sleep Behavior Disorder in Parkinson Disease Treated With Sodium Oxybate.

Liebenthal J, Valerio J, Ruoff C, Mahowald M.
JAMA Neurol. 2016 Jan;73(1):126-7. doi: 10.1001/jamaneurol.2015.2904. No abstract available.
Pub MED

Exome Variant Mining in Familial Parkinson Disease: Will Replication Find the Gold?

Toft M, Ross OA.
JAMA Neurol. 2016 Jan;73(1):21-2. doi: 10.1001/jamaneurol.2015.3536. No abstract available.
Pub MED

Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.

Dong J, Cui Y, Li S, Le W.
Curr Neuropharmacol. 2016;14(4):339-55. Review.
Pub MED

Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease.

Deas E, Cremades N, Angelova PR, Ludtmann MH, Yao Z, Chen S, Horrocks MH, Banushi B, Little D, Devine MJ, Gissen P, Klenerman D, Dobson CM, Wood NW, Gandhi S, Abramov AY.
Antioxid Redox Signal. 2016 Mar 1;24(7):376-91. doi: 10.1089/ars.2015.6343.
Pub MED

A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease.

Moccia M, Erro R, Picillo M, Santangelo G, Spina E, Allocca R, Longo K, Amboni M, Palladino R, Assante R, Pappatà S, Pellecchia MT, Barone P, Vitale C.
Sleep. 2016 Feb 1;39(2):405-12. doi: 10.5665/sleep.5452.
Pub MED

Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants.

Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei M.
Curr Pharm Des. 2016;22(2):238-46. Review.
Pub MED

Comparison of Intelligibility Measures for Adults With Parkinson's Disease, Adults With Multiple Sclerosis, and Healthy Controls.

Stipancic KL, Tjaden K, Wilding G.
J Speech Lang Hear Res. 2016 Apr 1;59(2):230-8. doi: 10.1044/2015_JSLHR-S-15-0271.
Pub MED

Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.

Negida A, Menshawy A, El Ashal G, Elfouly Y, Hani Y, Hegazy Y, El Ghonimy S, Fouda S, Rashad Y.
CNS Neurol Disord Drug Targets. 2016;15(1):45-53. Review.
Pub MED

Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.

Belaidi AA, Bush AI.
J Neurochem. 2016 Oct;139 Suppl 1:179-197. doi: 10.1111/jnc.13425. Review.
Pub MED

Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson's Disease.

Ferrucci R, Cortese F, Bianchi M, Pittera D, Turrone R, Bocci T, Borroni B, Vergari M, Cogiamanian F, Ardolino G, Di Fonzo A, Padovani A, Priori A.
Cerebellum. 2016 Feb;15(1):43-7. doi: 10.1007/s12311-015-0737-x.
Pub MED

DNAJC6 Mutations Associated With Early-Onset Parkinson's Disease.

Olgiati S, Quadri M, Fang M, Rood JP, Saute JA, Chien HF, Bouwkamp CG, Graafland J, Minneboo M, Breedveld GJ, Zhang J; International Parkinsonism Genetics Network., Verheijen FW, Boon AJ, Kievit AJ, Jardim LB, Mandemakers W, Barbosa ER, Rieder CR, Leenders KL, Wang J, Bonifati V.
Ann Neurol. 2016 Feb;79(2):244-56. doi: 10.1002/ana.24553.
Pub MED

miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease.

Mushtaq G, Greig NH, Anwar F, Zamzami MA, Choudhry H, Shaik MM, Tamargo IA, Kamal MA.
Med Chem. 2016;12(3):217-25. Review.
Pub MED

The nature of working memory gating in Parkinson's disease: A multi-domain signal detection examination.

Uitvlugt MG, Pleskac TJ, Ravizza SM.
Cogn Affect Behav Neurosci. 2016 Apr;16(2):289-301. doi: 10.3758/s13415-015-0389-9.
Pub MED

Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View.

Filograna R, Beltramini M, Bubacco L, Bisaglia M.
Curr Neuropharmacol. 2016;14(3):260-71. Review.
Pub MED

LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?

Taymans JM, Greggio E.
Curr Neuropharmacol. 2016;14(3):214-25. Review.
Pub MED

Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson's Disease.

Rivero-Ríos P, Madero-Pérez J, Fernández B, Hilfiker S.
Curr Neuropharmacol. 2016;14(3):238-49. Review.
Pub MED

Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson's Disease.

Nardin A, Schrepfer E, Ziviani E.
Curr Neuropharmacol. 2016;14(3):250-9. Review.
Pub MED

The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions.

Lewis MM, Du G, Lee EY, Nasralah Z, Sterlin NW, Zhang L, Wagner D, Kong L, Tröster AI, Styner M, Eslinger PJ, Mailman RB, Huang X.
J Neurol. 2016 Jan;263(1):68-75.
Pub MED

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.

Mollenhauer B, Parnetti L, Rektorova I, Kramberger MG, Pikkarainen M, Schulz-Schaeffer WJ, Aarsland D, Svenningsson P, Farotti L, Verbeek MM, Schlossmacher MG.
J Neurochem. 2016 Oct;139 Suppl 1:290-317. doi: 10.1111/jnc.13390. Review.
Pub MED

Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease.

Peng SP, Copray S.
Stem Cell Rev. 2016 Feb;12(1):105-20. doi: 10.1007/s12015-015-9623-7.
Pub MED

Test-Retest Reliability and Minimal Detectable Change for the 10-Meter Walk Test in Older Adults With Parkinson's disease.

Lang JT, Kassan TO, Devaney LL, Colon-Semenza C, Joseph MF.
J Geriatr Phys Ther. 2016 Oct-Dec;39(4):165-70. doi: 10.1519/JPT.0000000000000068.
Viendo del 1 al 40 de 3465 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.